Literature DB >> 6315443

Epstein-Barr virus markers in a series of Burkitt's lymphomas from the West Nile District, Uganda.

A Geser, G M Lenoir, M Anvret, G Bornkamm, G Klein, E H Williams, D H Wright, G De-The.   

Abstract

In an epidemiological survey in the West Nile District of Uganda, 70 pathologically confirmed BL cases were detected over a 5-yr period; this corresponded to an annual incidence rate of 1.6 per 100,000 general population or about 5 per 100,000 children in the age group 5-14 yr. Of the confirmed cases which were examined by EBV/DNA molecular hybridization, 96% were found to contain an average of 38 EBV genome equivalents per tumour cell, whereas none of the examined unconfirmed cases did. Duplicate hybridization assays in two laboratories were in close agreement. Serological testing showed that 91% of the confirmed BL cases had elevated EBV/VCA titres (greater than or equal to 160) and 64% were EA(D)-positive (greater than or equal to 10). Most of the cases with high EBV/genome content had high VCA titres, but there was a poor correlation between the two parameters among all cases. This study confirms that in high BL incidence areas the association between EBV and this lymphoma is almost constant, whereas it is exceptional in low-incidence areas. This further supports the aetiological implication of EBV in the endemicity of this tumor in equatorial Africa.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6315443     DOI: 10.1016/0277-5379(93)90009-t

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN: 0277-5379


  15 in total

1.  Identification of a novel protein encoded by the BamHI A region of the Epstein-Barr virus.

Authors:  K L Fries; T B Sculley; J Webster-Cyriaque; P Rajadurai; R H Sadler; N Raab-Traub
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

Review 2.  Human cancer and cellular oncogenes.

Authors:  S Nishimura; T Sekiya
Journal:  Biochem J       Date:  1987-04-15       Impact factor: 3.857

Review 3.  The role of c-myc in the proliferation of normal and neoplastic cells.

Authors:  K Kelly; U Siebenlist
Journal:  J Clin Immunol       Date:  1985-03       Impact factor: 8.317

4.  Epstein-Barr virus latent membrane protein 1 blocks p53-mediated apoptosis through the induction of the A20 gene.

Authors:  K L Fries; W E Miller; N Raab-Traub
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

5.  Cloned Shiga toxin 2 B subunit induces apoptosis in Ramos Burkitt's lymphoma B cells.

Authors:  Paola Marcato; George Mulvey; Glen D Armstrong
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

6.  Alterations of the p53 gene in Epstein-Barr virus-associated immunodeficiency-related lymphomas.

Authors:  R H Edwards; N Raab-Traub
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

7.  No evidence for differences in the Epstein-Barr virus genome carried in Burkitt lymphoma cells and nonmalignant lymphoblastoid cells from the same patients.

Authors:  G W Bornkamm; M von Knebel-Doeberitz; G M Lenoir
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

8.  EBV, HHV8 and HIV in B cell non Hodgkin lymphoma in Kampala, Uganda.

Authors:  Lynnette K Tumwine; Jackson Orem; Patrick Kerchan; Wilson Byarugaba; Stefano A Pileri
Journal:  Infect Agent Cancer       Date:  2010-06-30       Impact factor: 2.965

Review 9.  Immune regulation in Epstein-Barr virus-associated diseases.

Authors:  R Khanna; S R Burrows; D J Moss
Journal:  Microbiol Rev       Date:  1995-09

10.  p53 is frequently mutated in Burkitt's lymphoma cell lines.

Authors:  P J Farrell; G J Allan; F Shanahan; K H Vousden; T Crook
Journal:  EMBO J       Date:  1991-10       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.